Blood clots on a chip: New model could improve thromboinflammation treatment
Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack, and stroke.
Apr 3, 2025
0
20
Blood clots are associated with life-threatening conditions such as sepsis, sickle cell disease, heart attack, and stroke.
Apr 3, 2025
0
20
A clot-busting drug recently approved to treat acute ischemic strokes (AIS) that can be delivered quickly works as well as a decades-old medication used by most hospitals in the U.S. and could hold significant advantages ...
Mar 13, 2025
0
18
The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Mar 6, 2025
0
16
The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and Lancet Neurology—the ...
Feb 18, 2025
0
17
The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented ...
Feb 8, 2025
0
20
During an ischemic stroke, blood vessels in the brain are blocked or narrowed. During a hemorrhagic stroke, there's bleeding into the brain. The first treatment for stroke is to potentially offer a medication called tissue ...
Feb 3, 2025
0
26
In the not-so-distant past, doctors treated strokes in an after-the-fact way. A stroke did its damage, and then—if the patient survived—a rehabilitation team stepped in to address the stroke's effects.
Nov 21, 2024
0
21
It's been more than three decades, but still there are only two treatments for a stroke: either rapid use of a clot-busting medication called tPA or surgical removal of a clot from the brain with mechanical thrombectomy. ...
Oct 28, 2024
0
97
For patients with acute ischemic stroke (AIS), tenecteplase (TNK) has improved functional outcome and reduced disability and similar safety to alteplase (tissue plasminogen activator [TPA]), according to a study published ...
Oct 17, 2024
0
18
For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later than the drug alteplase, ...
Oct 16, 2024
0
23